MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
161.25%
Quick Ratio
160.22%
Cash Ratio
34.07%
Debt to Asset Ratio
46.62%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • PONVORY
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Product revenue allowances
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
55,882
54,034
84,851
70,022
Marketable securities
114,147
148,276
178,996
223,730
Accounts receivable, net
59,692
56,879
54,578
50,541
Inventory
1,678
1,699
1,852
2,042
Prepaid expenses and other current assets
33,085
32,281
26,985
21,161
Total current assets
264,484
293,169
347,262
367,496
Property and equipment, net
2,578
2,245
2,248
2,460
Operating lease right-of-use assets
14,598
4,536
3,923
4,368
Finance lease right-of-use assets
6,772
7,284
7,343
5,071
2026
731
1,097
-
366
2027
1,463
1,463
1,463
1,463
2028
1,463
1,463
1,463
1,463
2029
1,463
1,463
1,463
1,463
2030
1,463
1,463
1,463
1,463
2030
-
-
1,463
-
Thereafter
6,824
6,822
6,822
8,285
Hetlioz
13,407
13,771
14,137
14,503
2026
2,772
4,158
-
1,386
2027
5,544
5,544
5,544
5,544
2028
5,544
5,544
5,544
5,544
2029
5,544
5,544
5,544
5,544
2030
5,544
5,544
5,544
5,544
2030
-
-
5,544
-
Thereafter
65,232
65,232
65,232
70,776
PONVORY
90,180
91,566
92,952
94,338
2026
471
706
-
-
2027
941
941
941
-
2028
941
941
941
-
2029
941
941
941
-
2030
941
941
941
-
2030
-
-
941
-
Thereafter
5,293
5,295
5,295
-
NEREUS
9,528
9,765
10,000
-
Intangible assets, net
113,115
115,102
117,089
108,841
Deferred tax assets
-
-
0
103,073
Non-current inventory and other
10,920
11,189
11,083
9,831
Total assets
412,467
433,525
488,948
601,140
Accounts payable and accrued liabilities
69,994
60,620
68,297
47,619
Product revenue allowances
94,032
74,962
76,865
70,251
Total current liabilities
164,026
135,582
145,162
117,870
Operating lease non-current liabilities
15,027
3,266
2,991
3,419
Finance lease non-current liabilities
3,175
3,785
4,076
2,808
Other non-current liabilities
10,054
10,127
9,533
11,044
Total liabilities
192,282
152,760
161,762
135,141
Common stock, 0.001 par value 150,000,000 shares authorized 60,454,687 and 59,101,630 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
60
60
59
59
Additional paid-in capital
725,933
723,826
721,264
718,979
Accumulated other comprehensive income
38
212
629
540
Accumulated deficit
-505,846
-443,333
-394,766
-253,579
Total stockholders equity
220,185
280,765
327,186
465,999
Total liabilities and stockholders equity
412,467
433,525
488,948
601,140
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Thereafter$65,232K 2030$5,544K 2029$5,544K 2028$5,544K 2027$5,544K 2026$2,772K Thereafter$6,824K 2030$1,463K 2029$1,463K 2028$1,463K 2027$1,463K 2026$731K Thereafter$5,293K 2030$941K 2029$941K 2028$941K 2027$941K 2026$471K Marketable securities$114,147K (-53.33%↓ Y/Y)Accounts receivable, net$59,692K (32.67%↑ Y/Y)Cash and cashequivalents$55,882K (-31.00%↓ Y/Y)Prepaid expenses andother current assets$33,085K (48.97%↑ Y/Y)Inventory$1,678K (-22.64%↓ Y/Y)PONVORY$90,180K Hetlioz$13,407K NEREUS$9,528K Total current assets$264,484K (-33.03%↓ Y/Y)Intangible assets, net$113,115K (2.28%↑ Y/Y)Operating leaseright-of-use assets$14,598K (203.87%↑ Y/Y)Non-current inventory andother$10,920K (13.50%↑ Y/Y)Finance leaseright-of-use assets$6,772K (29.14%↑ Y/Y)Property and equipment,net$2,578K (6.53%↑ Y/Y)Total assets$412,467K (-33.98%↓ Y/Y)Total liabilities andstockholders equity$412,467K (-33.98%↓ Y/Y)Total stockholdersequity$220,185K (-54.73%↓ Y/Y)Total liabilities$192,282K (38.92%↑ Y/Y)Accumulated deficit-$505,846K (-118.99%↓ Y/Y)Additional paid-in capital$725,933K (1.26%↑ Y/Y)Total currentliabilities$164,026K (35.01%↑ Y/Y)Operating leasenon-current liabilities$15,027K (287.59%↑ Y/Y)Other non-currentliabilities$10,054K (0.86%↑ Y/Y)Finance leasenon-current liabilities$3,175K (2.98%↑ Y/Y)Common stock, 0.001 parvalue 150,000,000...$60K (1.69%↑ Y/Y)Accumulated othercomprehensive income$38K (-90.40%↓ Y/Y)Product revenueallowances$94,032K (46.08%↑ Y/Y)Accounts payable andaccrued liabilities$69,994K (22.54%↑ Y/Y)

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA)